STOCK TITAN

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Key Terms

minimum bid price rule regulatory
A minimum bid price rule is a stock market requirement that a listed company's share must trade above a set minimum price over a specified period to remain listed on an exchange. It matters to investors because falling below that threshold can trigger warnings, potential delisting, and reduced liquidity—similar to a student needing a passing grade to stay enrolled—making the shares harder to buy, sell, or value accurately.
common stock financial
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
reverse stock-split financial
A reverse stock split reduces the number of a company's outstanding shares by combining multiple existing shares into one new share (for example, five old shares become one new share), which raises the per-share price without changing the overall value of an investor’s holdings. Investors care because it can make a stock look healthier or meet exchange listing rules, but it does not by itself improve the company’s business or the total value of their investment—think of repackaging many small coins into fewer larger coins.

LAKE FOREST, Ill.--(BUSINESS WIRE)-- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with all applicable listing requirements.

As of January 12, 2026, Nasdaq has determined that Assertio has regained compliance with the Minimum Bid Price Rule, which requires the Company’s common stock maintains a minimum bid price of $1.00 per share for a minimum of ten consecutive days, and that the matter is now closed.

Mark Reisenauer, Chief Executive Officer of Assertio: “We are pleased to have regained compliance with applicable listing requirements. Importantly, we accomplished this efficiently with the successful completion of our December 2025 reverse stock-split, while preserving capital allocation flexibility.”

About Assertio
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management.

Forward Looking Statements

Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio’s current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, future events or the future performance or operations of Assertio, including statements about the Reverse Split. All statements other than historical facts may be forward-looking statements and can be identified by words such as “anticipate,” ‘believe,” “could,” “design,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may,” “objective,” “opportunity,” “outlook,” “plan,” “position,” “potential,” “predict,” “project,” “prospective,” “pursue,” “seek,” “should,” “strategy,” “target,” “would,” “will,” “aim” or other similar expressions that convey the uncertainty of future events or outcomes are used to identify forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the control of Assertio.

Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks are more fully described in Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the SEC and in other filings Assertio makes with the SEC from time to time. Investors and potential investors are urged not to place undue reliance on forward-looking statements in this communication, which speak only as of this date. While Assertio may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to update or revise any forward-looking-statements contained in this press release whether as a result of new information or future events, except as may be required by applicable law. Nothing contained herein constitutes or will be deemed to constitute a forecast, projection or estimate of the future financial performance or expected results of Assertio.

Investor Contact

Longacre Square Partners

assertio@longacresquare.com

Source: Assertio Holdings, Inc.

Assertio Holdings Inc

NASDAQ:ASRT

ASRT Rankings

ASRT Latest News

ASRT Latest SEC Filings

ASRT Stock Data

71.42M
6.26M
2.51%
26.86%
5.02%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
LAKE FOREST